• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Dermpath

Anonymous board for Dermpath
Replies
1
Views
3K
Anonymous
Replies
5
Views
5K
Anonymous
Replies
2
Views
3K
Anonymous
Replies
6
Views
4K
Anonymous
Replies
7
Views
4K
Anonymous
Replies
3
Views
6K
Anonymous